RHON-KLINIKUM AG (0NQH) Price & Analysis

0 Followers

0NQH Stock Chart & Stats

€13.20

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€13.20

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€11.50 - €15.30

Previous CloseN/A

Volume0.00

Average Volume (3M)82.00

Market Cap

€977.30M

Enterprise Value€889.42

Total Cash (Recent Filing)€556.55M

Total Debt (Recent Filing)€121.88M

Price to Earnings (P/E)22.8

Beta-0.22

Next Earnings

Nov 05, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.64

Shares Outstanding66,962,470

10 Day Avg. Volume0

30 Day Avg. Volume82

Financial Highlights & Ratios

PEG Ratio-1.22

Price to Book (P/B)0.64

Price to Sales (P/S)0.44

P/FCF Ratio-24.57

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)0.64

Revenue Forecast (FY)€1.79B

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a growing equity base provide RHÖN-KLINIKUM with meaningful financial resilience. This reduces balance-sheet risk, supports continued hospital investment, and gives management greater flexibility to manage earnings volatility without relying heavily on additional borrowing.

Recent Revenue ExpansionThe strong 2025 revenue rebound indicates that the hospital platform can regain growth after a weaker year. Expanding treatment activity or reimbursement revenue can support operating scale and create a foundation for improved earnings if cost control catches up.

Broad Healthcare Services PlatformA broad hospital and medical-services offering gives RHÖN-KLINIKUM multiple ways to serve patients across care settings and specialties. Integrated diagnostics, therapy, and ancillary services can deepen patient relationships and support a more durable healthcare operating model.

Bears Say

Sharp Operating Profit DeteriorationThe steep EBIT decline while revenue increased signals substantial pressure on operating profitability. Unless the company restores cost discipline or improves treatment economics, continued weak operating earnings could limit reinvestment capacity and reduce the benefit of future revenue growth.

Negative Latest Free Cash FlowNegative free cash flow reduces internally generated funding for hospital investment and other strategic priorities. Although earlier years produced positive free cash flow, persistence of the 2025 reversal would weaken funding flexibility and make cash conversion an important medium-term risk.

Thin Profitability And Modest ReturnsLow margins leave limited protection against cost increases or operational setbacks, while modest returns on equity indicate that the substantial asset base is generating relatively restrained profitability. This constrains earnings compounding unless operating efficiency improves.

0NQH FAQ

What was RHON-KLINIKUM AG’s price range in the past 12 months?

RHON-KLINIKUM AG lowest share price was €11.50 and its highest was €15.30 in the past 12 months.

What is RHON-KLINIKUM AG’s market cap?

RHON-KLINIKUM AG’s market cap is €977.30M.

When is RHON-KLINIKUM AG’s upcoming earnings report date?

RHON-KLINIKUM AG’s upcoming earnings report date is Nov 05, 2026 which is in 59 days.

How were RHON-KLINIKUM AG’s earnings last quarter?

RHON-KLINIKUM AG released its earnings results on Aug 06, 2026. The company reported €0.135 earnings per share for the quarter.

Is RHON-KLINIKUM AG overvalued?

According to Wall Street analysts RHON-KLINIKUM AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does RHON-KLINIKUM AG pay dividends?

RHON-KLINIKUM AG does not currently pay dividends.

What is RHON-KLINIKUM AG’s EPS estimate?

RHON-KLINIKUM AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does RHON-KLINIKUM AG have?

RHON-KLINIKUM AG has 66,962,470 shares outstanding.

What happened to RHON-KLINIKUM AG’s price movement after its last earnings report?

RHON-KLINIKUM AG reported an EPS of €0.135 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of RHON-KLINIKUM AG?

Currently, no hedge funds are holding shares in GB:0NQH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

RHON-KLINIKUM AG Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

1.42%

Trailing 12-Months

Asset Growth

-2.06%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

RHON-KLINIKUM AG

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, delivers extensive healthcare services across Germany, encompassing inpatient, day-patient, and outpatient treatment models. The company's hospitals provide a broad spectrum of medical and surgical care, including cardiovascular rehabilitation, specialized hand and trauma surgery, neurological and psychosomatic treatments, addiction therapy, ophthalmology, and dentistry. They also address conditions affecting the thoracic region, lungs, and vascular system, offer oncology services, and manage neurological conditions, spinal column and joint issues, as well as heart diseases. The organization operates eight hospitals, providing a total of 5,420 beds or patient slots across five distinct medical locations. RHÖN-KLINIKUM is headquartered in Bad Neustadt an der Saale, Germany.